The Pakistan Paediatric Association (PPA) has formally requested the Drug Regulatory Authority of Pakistan (Drap) to grant an exemption or targeted exclusion for 10cc conventional syringes, citing critical clinical factors to safeguard public health.

A delay by Pakistan's federal cabinet in deciding on medicine price revisions has led to severe shortages and increased risks of counterfeiting. The Drug Regulatory Authority of Pakistan (DRAP) had recommended price adjustments for 105 hardship-category medicines over two years ago.

The Drug Regulatory Authority of Pakistan (Drap) is seeking a crackdown on websites and social media platforms facilitating the spread of illegal drugs.